Michael A. Luther Ph.D., MBA

President & Chief Executive Officer

Dr. Luther has 30+ years of extensive expertise in building, implementing and successfully leading biopharmaceutical companies and operations. His experiences include leadership roles ranging from virtual start-ups to leading major divisions for global pharmaceutical companies with roles in drug development, manufacturing, and business development. Dr. Luther served as president and CEO of Bantam Pharmaceutical, senior VP of discovery and development at AMRI, Inc., VP and head of R&D at Merck-Canada and VP of discovery at GSK. Dr. Luther holds a B.S. in Biology and Chemistry from North Carolina State, an MBA from the Duke University Fuqua School of Business and a Ph.D. in Biochemistry from the St. Louis University School of Medicine.

Steve Orndorff Ph.D.

Chief Operating Officer

Dr. Orndorff is a seasoned business executive, scientist and serial entrepreneur with 30 years of experience in the biotechnology industry in various roles of management, business development, R&D, commercialization and manufacturing. Prior to Teewinot, Dr. Orndorff served as president and CEO of IM Therapeutics, president and CEO of MicroBiome Therapeutics LLC and founder and CEO of Accera, Inc. He is past chairman of Colorado Institute for Drug, Device and Diagnostic Development. Dr. Orndorff holds a B.S. in Biology from Virginia Polytechnic Institute and a Ph.D. in Microbiology from the University of Maryland.